Elsevier

Drug and Alcohol Dependence

Volume 154, 1 September 2015, Pages 1-13
Drug and Alcohol Dependence

Review
Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis

https://doi.org/10.1016/j.drugalcdep.2015.05.031Get rights and content

Highlights

  • A systematic review was conducted to assess comorbidity between substance use, mood and anxiety disorders.

  • Meta-analysis showed the strongest associations were for drug use and major depression (OR 3.80).

  • People with an alcohol use disorder were 2.1 times of greater risk having an anxiety disorder than non-users.

  • Comorbidity was higher for people with drug or alcohol dependence than those with abuse.

  • Comorbid prevalence rates were similar between current (1 year) and lifetime drug or alcohol users.

Abstract

Background

Comorbidity is highly prevalent between substance use disorders (SUDs), mood and anxiety disorders. We conducted a systematic review and meta-analysis to determine the strength of association between SUDs, mood and anxiety disorders in population-based epidemiological surveys.

Methods

A comprehensive literature search of Medline, EMBASE, CINAHL, PsychINFO, Web of Science, and Scopus was conducted from 1990 to 2014. Sources were chosen on the basis that they contained original research in non-clinical populations conducted in randomly selected adults living within defined boundaries. Prevalence of comorbid SUDs, mood and anxiety disorders and odds ratios (ORs) were extracted.

Results

There were 115 articles identified by electronic searches that were reviewed in full text which yielded 22 unique epidemiological surveys to extract lifetime and 12-month prevalence data for psychiatric illness in respondents with an SUD. Meta-analysis indicated the strongest associations were between illicit drug use disorder and major depression (pooled OR 3.80, 95% CI 3.02–4.78), followed by illicit drug use and any anxiety disorder (OR 2.91, 95% CI 2.58–3.28), alcohol use disorders and major depression (OR 2.42, 95% CI 2.22–2.64) and alcohol use disorders and any anxiety disorder (OR 2.11, 95% CI 2.03–2.19). ORs for dependence were higher than those for abuse irrespective to diagnoses based on lifetime or 12-month prevalence.

Conclusions

This review confirms the strong association between SUDs, mood and anxiety disorders. The issue has now been recognised worldwide as a factor that affects the profile, course, patterns, severity and outcomes of these disorders.

Introduction

The issue of substance use disorders (SUDs) comorbid with mental health disorders has gained increasing prominence in psychiatry and drug health over the last 30 years. There is overwhelming evidence that SUDs are more prevalent among people with severe mental health disorders than among the general population (Kessler, 2004, Menezes et al., 1996, Merikangas and Kalaydjian, 2007, Regier et al., 1990, Rosenthal et al., 2012) which have contributed to the high burden of disease worldwide (Whiteford et al., 2013, Wittchen et al., 2011). Current reasoning to explain the high rates of comorbidity are that one mental disorder may directly influence another, such as heavy alcohol use may produce depression in persons who are alcohol dependent (Cerda et al., 2008, Hall et al., 2009). Comorbidity may also be indirectly produced such as when substances are used for self-medication or for relieving distress of a mental disorder, e.g., sustained use may lead to dependence. A third possibility is that comorbidity may arise from common shared causes through genetic predisposition or socioeconomic factors, such a poverty or trauma or transmitted within the family (Cerda et al., 2008, Kushner et al., 2000). The high comorbidity rates may also be due to increased access and opportunity to use illicit drugs in the community (Liang et al., 2011) with the closure of large psychiatric hospitals over the last three decades.

Since comorbid mental health disorders are usually associated with poor treatment outcomes this leads to severe illness and high levels of health service utilisation (Kessler et al., 1994, Kessler, 2004, Merikangas and Gelernter, 1990). Yet despite the high rates of comorbidity between substance use, mood and anxiety disorders, the problem remains poorly understood and is often missed as a diagnosis among clinicians practising in either field (Cuffel, 1996, Tickell, 1999). A better understanding of comorbidity is needed to identify the correlational and/or potential causal relationships among symptoms, disorders and treatment in comorbid patients. Such knowledge will also make an important contribution to treatment and prevention strategies.

In epidemiologic surveys, comorbid prevalence rates can be expressed in two ways: the prevalence of SUDs among respondents with a mental health disorder or the prevalence of psychiatric cases among respondents with a SUD. The prevalence rates between the two populations can vary considerably due to their frequency of occurrence. Take for instance the prevalence of major depression and illicit drug dependence reported by Grant et al. (2004). Amongst respondents with any drug dependence, the prevalence of major depression was ∼40%, whereas the prevalence of any drug dependence amongst respondents with major depression was 3.5%. Conversely, the prevalence of any SUD in respondents with mania was ∼30% compared to the prevalence of mania (∼5%) in respondents with a SUD (Grant et al., 2004). Nonetheless, even large national studies have limited reporting capacity of comorbid prevalence rates within general populations where one or both disorders are of low prevalence (such as schizophrenia and intravenous drug use or methamphetamine use) where the resulting comorbid sample size is small and variance estimates large.

Many epidemiology surveys report prevalence rates for individual mental health and various SUDs but often do not report comorbid prevalence rates, although sometimes these are reported in subsequent analyses (e.g., Merikangas et al., 1998, Swendsen et al., 1998). Jane-Llopis and Matytsina (2006) reported comorbid prevalence of mental health disorders and SUDs and their relationship to be highly prevalent across high income countries. This was not a systematic review and included only nine surveys conducted between 1998 and 2005. However, this review found that people with a SUD had higher comorbid rates of mental health disorders than vice versa and that people with illicit drug use disorders (DUDs) had higher rates of mental health disorders than those with alcohol use disorders (AUDs) (Jane-Llopis and Matytsina, 2006).

The aim of this systematic review is to report and combine the findings of surveys based on large epidemiological populations reporting prevalence rates of SUDs comorbid with mood and anxiety disorders from studies conducted between 1990 and 2014. We chose 1990 as a starting point to include the influential Epidemiologic Catchment Area (ECA) study and subsequent surveys using similar large scale census techniques and face to face interviews to report prevalence rates using American Psychiatric Association-Diagnostic and Statistical Manual (DSM) or World Health Organisation-International Classification (WHO, ICD) diagnostic instruments from diverse geographic sites. Prevalence of mood and anxiety disorders in respondents with an SUD was collated for lifetime and current (1 year) abuse or dependence of alcohol or illicit drugs. SUDs comorbid with any anxiety disorders included agoraphobia, generalised anxiety disorders (GAD), panic disorder and social phobia. Mood disorders included bipolar disorder, major depression and dysthymia.

The odds (or odds ratio, OR) of having major depression or any anxiety disorder among individuals with alcohol or illicit drug use was used in the meta-analysis because it is not affected by differences in calculating prevalence rates of SUDs within populations with mental health disorders or vice versa. The reason comorbidity rates for major depression and any anxiety disorder were selected for the meta-analysis was that they are commonly reported and comorbidity for specific psychiatric diagnoses or specific substances (cannabis, heroin, cocaine, etc.) are under reported. The current review excludes studies of clinical or treatment-seeking populations as these will be the subject of subsequent reviews. Studies based within these clinical setting will have greater power than general population surveys to reveal associations between particular mental illnesses of low prevalence (schizophrenia, bipolar disorders, etc.) and licit and illicit substance dependence. Thus, the systematic literature search used in this review also used terms to include surveys conducted in clinical settings reporting comorbid prevalence rates for low prevalence SUD and mental health disorders to be used in future reviews.

Section snippets

Methods

Methods were based on the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines (Liberati et al., 2009, Moher et al., 2009) and guidelines for Meta-Analysis for Observational Studies in Epidemiology (MOOSE) (Stroup et al., 2000).

Search findings

A total of 1649 titles were found after removal of duplicates from electronic searches (Fig. 1). Among them, 1254 articles were judged not relevant by titles by two independent reviewers leaving 395 articles to be examined for comorbid prevalence rates. Of the 395 articles, 148 articles were judged by two independent reviewers not relevant by viewing abstract (n = 18) or full text (n = 130) and the remaining 247 articles were classified according to population setting. Of the 247 articles, there

Discussion

This systematic review and meta-analyses found strong associations between co-occurring SUDs with major depression and any anxiety disorder. The strongest associations were found between illicit drug use and major depression (pooled OR 3.803), followed by illicit drug use and any anxiety disorder (pooled OR 2.907), alcohol use and major depression (pooled OR 2.423) and alcohol use and any anxiety disorder (pooled OR 2.111). Sub-analyses indicated ORs for AUDs and DUDs were higher for dependence

Conclusion

This systematic review of epidemiological studies in general populations over the last 25 years shows comorbidity between SUDs, mood and anxiety disorders are highly prevalent across countries. The meta-analysis revealed that people with an alcohol use disorder (abuse or dependence) were 2.1 times of greater risk of having any anxiety disorder compared to those without an AUD and this association was higher for AUDs and major depression showing that the risk of having major depression is 3.10

Authors disclosures

Authors have nothing to disclose.

Role of funding source

No financial support was received for this study. Portions of these data were used for the submission of a dissertation by HL for a doctorate of philosophy.

Contributors

HL and GH were responsible for the development of the research question, article searching, interpretation of the data and writing the draft manuscript. HL, GH and MC were responsible for screening articles and data extraction. GH and MC conducted the assessment of bias. GH performed the meta-analysis and produced the figures. TS was responsible for the development of the research question, critical revision of the manuscript and was the primary supervisor of the project. All authors have

Conflict of interest

No conflict declared.

References (101)

  • M.G. Kushner et al.

    The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings

    Clin. Psychol. Rev.

    (2000)
  • E. Leray et al.

    Prevalence, characteristics and comorbidities of anxiety disorders in France: results from the “Mental Health in General Population” survey (MHGP)

    Eur. Psychiatry

    (2011)
  • M.P. McGovern et al.

    Addiction treatment services and co-occurring disorders: prevalence estimates, treatment practices, and barriers

    J. Subst. Abuse Treat.

    (2006)
  • A.A. Mericle et al.

    Prevalence, patterns, and correlates of co-occurring substance use and mental disorders in the United States: variations by race/ethnicity

    Compr. Psychiatry

    (2012)
  • K.R. Merikangas et al.

    Comorbidity for alcoholism and depression

    Psychiatr. Clin. N. Am.

    (1990)
  • K.R. Merikangas et al.

    Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology

    Addict. Behav.

    (1998)
  • M. Subramaniam et al.

    Prevalence, correlates, comorbidity and severity of bipolar disorder: results from the Singapore Mental Health Study

    J. Affect. Disord.

    (2013)
  • S. Suttajit et al.

    Risks of major depressive disorder and anxiety disorders among Thais with alcohol use disorders and illicit drug use: findings from the 2008 Thai National Mental Health survey

    Addict. Behav.

    (2012)
  • J.A. Swartz et al.

    Screening for serious mental illness in populations with co-occurring substance use disorders: performance of the K6 scale

    J. Subst. Abuse Treat.

    (2006)
  • J.D. Swendsen et al.

    The comorbidity of depression and substance use disorders

    Clin. Psychol. Rev.

    (2000)
  • J.D. Swendsen et al.

    The comorbidity of alcoholism with anxiety and depressive disorders in four geographic communities

    Compr. Psychiatry

    (1998)
  • W.A. Vega et al.

    Prevalence and correlates of dual diagnoses in US

    Latinos. Drug Alcohol Depend.

    (2009)
  • H.A. Whiteford et al.

    Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010

    Lancet

    (2013)
  • M. Alegria et al.

    Considering context, place and culture: the National Latino and Asian American Study

    Int. J. Methods Psychiatr. Res.

    (2004)
  • N. Almeida-Filho et al.

    Co-occurrence patterns of anxiety, depression and alcohol use disorders

    Eur. Arch. Psychiatry Clin. Neurosci.

    (2007)
  • J. Alonso et al.

    12-Month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

    Acta Psychiatr. Scand.

    (2004)
  • J. Alonso et al.

    Overview of key data from the European Study of the Epidemiology of Mental Disorders (ESEMeD)

    J. Clin. Psychiatry

    (2007)
  • J. Alonso et al.

    Including information about co-morbidity in estimates of disease burden: results from the World Health Organization World Mental Health Surveys

    Psychol. Med.

    (2011)
  • J. Angst et al.

    The Zurich study – a prospective epidemiological study of depressive, neurotic and psychosomatic syndromes. I. Problem, methodology

    Eur. Arch. Psychiatry Neurol. Sci.

    (1984)
  • R.V. Bijl et al.

    Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS)

    Soc. Psychiatry Psychiatr. Epidemiol.

    (1998)
  • K. Bott et al.

    Psychiatric disorders among at-risk consumers of alcohol in the general population

    J. Stud. Alcohol

    (2005)
  • E.J. Bromet et al.

    Epidemiology of psychiatric and alcohol disorders in Ukraine: findings from the Ukraine World Mental Health survey

    Soc. Psychiatry Psychiatr. Epidemiol.

    (2005)
  • A. Bulloch et al.

    Alcohol consumption and major depression in the general population: the critical importance of dependence

    Depress. Anxiety

    (2012)
  • G.J. Canino et al.

    The prevalence of specific psychiatric disorders in Puerto Rico

    Arch. Gen. Psychiatry

    (1987)
  • J.J. Caraveo-Anduaga et al.

    Psychiatric disorders and substance abuse in Mexico: epidemiological perspective

    Salud Mental

    (2002)
  • M. Cerda et al.

    Comorbid forms of psychopathology: key patterns and future research directions

    Epidemiol. Rev.

    (2008)
  • M.J. Cho et al.

    Lifetime and 12-month prevalence of DSM-IV psychiatric disorders among Korean adults

    J. Nerv. Ment. Dis.

    (2007)
  • S.P. Chou et al.

    Alcohol use disorders, nicotine dependence, and co-occurring mood and anxiety disorders in the United States and South Korea – a cross-national comparison

    Alcohol Clin. Exp. Res.

    (2012)
  • W.M. Compton et al.

    Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions

    Arch. Gen. Psychiatry

    (2007)
  • K.P. Conway et al.

    Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on alcohol and related conditions

    J. Clin. Psychiatry

    (2006)
  • V. Crawford et al.

    Co-existing problems of mental health and substance misuse (dual diagnosis): a literature review

    Drug-Educ. Prev. Polic.

    (2003)
  • B.J. Cuffel

    Comorbid substance use disorder: prevalence, patterns of use, and course

    New Dir. Ment. Health Serv.

    (1996)
  • S.R. Currie et al.

    Comorbidity of major depression with substance use disorders

    Can. J. Psychiatry

    (2005)
  • R. De Graaf et al.

    Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study

    Am. J. Psychiatry

    (2002)
  • L. Degenhardt et al.

    Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys

    PLoS Med.

    (2008)
  • K. Dickersin

    Systematic reviews in epidemiology: why are we so far behind?

    Int. J. Epidemiol.

    (2002)
  • N.R. Eaton et al.

    The structure and predictive validity of the internalizing disorders

    J. Abnorm. Psychol.

    (2013)
  • M. Farrell et al.

    Nicotine, alcohol and drug dependence and psychiatric comorbidity: results of a national household survey

    Br. J. Psychiatry

    (2001)
  • H.L. Graham et al.

    Drug and alcohol problems amongst individuals with severe mental health problems in an inner city area of the UK

    Soc. Psychiatry Psychiatr. Epidemiol.

    (2001)
  • B.F. Grant et al.

    Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on alcohol and related conditions

    Mol. Psychiatr.

    (2009)
  • Cited by (583)

    View all citing articles on Scopus
    View full text